DolphinBench

Test 066

Jan 1, 2028 / 5 facts

YAML

Request

Create a new document titled “Q4 Pricing Path Clarity Test — completed metric scorecard.” Summarize the completed experiment in a concise scorecard covering total traffic and arm counts, the routed-out primary result, admission-completion and support-time guardrails, consistency across the weekly and stabilization cohorts, and the concurrent pricing-page change check.

Required memory

Fact 152

Owen certified the completed four-cohort Q4 Pricing Path Clarity Test read.

Source evidence (1)

003470Nov 19, 2025 / 09:18 UTC-06:00

Owen has certified the completed four-cohort Q4 Pricing Path Clarity Test read. Across 3,286 organic pricing-page sessions, there were 1,639 control and 1,647 treatment sessions. Among Helio Start eligibility-flow starts, 38 of 344 control starts (11.0%) versus 25 of 352 treatment starts (7.1%) routed out for an existing unsupported condition, a 35.7% relative reduction. Eligible-workspace admission completion was 43.8% in control and 44.1% in treatment, and account-level support time at the 90th percentile was 71 minutes in control and 74 minutes in treatment. The direction held in all three weekly cohorts and the November 10–16 stabilization cohort, with no unrelated pricing-page layout or UI change. This clears the predeclared path-quality threshold and both guardrails. Update the existing “Q4 Pricing Path Clarity Test — design brief” with the certified denominators, result, guardrails, attribution check, and my recommendation to adopt treatment for organic traffic while leaving every admission and acquisition boundary unchanged. Make clear that this supports fewer unsupported self-serve starts and a pricing-page rollout decision—not paid-acquisition economics, pipeline impact, forecast credit, revenue lift, or a change to Helio Start eligibility—and that treatment remains non-default pending Priya’s November 25 decision.

Message 003470 in history

Fact 153

The Q4 Pricing Path Clarity Test covered 3,286 organic pricing-page sessions: 1,639 control sessions and 1,647 treatment sessions.

Source evidence (1)

003470Nov 19, 2025 / 09:18 UTC-06:00

Owen has certified the completed four-cohort Q4 Pricing Path Clarity Test read. Across 3,286 organic pricing-page sessions, there were 1,639 control and 1,647 treatment sessions. Among Helio Start eligibility-flow starts, 38 of 344 control starts (11.0%) versus 25 of 352 treatment starts (7.1%) routed out for an existing unsupported condition, a 35.7% relative reduction. Eligible-workspace admission completion was 43.8% in control and 44.1% in treatment, and account-level support time at the 90th percentile was 71 minutes in control and 74 minutes in treatment. The direction held in all three weekly cohorts and the November 10–16 stabilization cohort, with no unrelated pricing-page layout or UI change. This clears the predeclared path-quality threshold and both guardrails. Update the existing “Q4 Pricing Path Clarity Test — design brief” with the certified denominators, result, guardrails, attribution check, and my recommendation to adopt treatment for organic traffic while leaving every admission and acquisition boundary unchanged. Make clear that this supports fewer unsupported self-serve starts and a pricing-page rollout decision—not paid-acquisition economics, pipeline impact, forecast credit, revenue lift, or a change to Helio Start eligibility—and that treatment remains non-default pending Priya’s November 25 decision.

Message 003470 in history

Fact 154

Among Helio Start eligibility-flow starts in the Q4 Pricing Path Clarity Test, 38 of 344 control starts (11.0%) and 25 of 352 treatment starts (7.1%) routed out for an existing unsupported condition, a 35.7% relative reduction.

Source evidence (1)

003470Nov 19, 2025 / 09:18 UTC-06:00

Owen has certified the completed four-cohort Q4 Pricing Path Clarity Test read. Across 3,286 organic pricing-page sessions, there were 1,639 control and 1,647 treatment sessions. Among Helio Start eligibility-flow starts, 38 of 344 control starts (11.0%) versus 25 of 352 treatment starts (7.1%) routed out for an existing unsupported condition, a 35.7% relative reduction. Eligible-workspace admission completion was 43.8% in control and 44.1% in treatment, and account-level support time at the 90th percentile was 71 minutes in control and 74 minutes in treatment. The direction held in all three weekly cohorts and the November 10–16 stabilization cohort, with no unrelated pricing-page layout or UI change. This clears the predeclared path-quality threshold and both guardrails. Update the existing “Q4 Pricing Path Clarity Test — design brief” with the certified denominators, result, guardrails, attribution check, and my recommendation to adopt treatment for organic traffic while leaving every admission and acquisition boundary unchanged. Make clear that this supports fewer unsupported self-serve starts and a pricing-page rollout decision—not paid-acquisition economics, pipeline impact, forecast credit, revenue lift, or a change to Helio Start eligibility—and that treatment remains non-default pending Priya’s November 25 decision.

Message 003470 in history

Fact 155

The Q4 Pricing Path Clarity Test recorded eligible-workspace admission completion of 43.8% for control and 44.1% for treatment, with account-level support time at the 90th percentile of 71 minutes for control and 74 minutes for treatment.

Source evidence (1)

003470Nov 19, 2025 / 09:18 UTC-06:00

Owen has certified the completed four-cohort Q4 Pricing Path Clarity Test read. Across 3,286 organic pricing-page sessions, there were 1,639 control and 1,647 treatment sessions. Among Helio Start eligibility-flow starts, 38 of 344 control starts (11.0%) versus 25 of 352 treatment starts (7.1%) routed out for an existing unsupported condition, a 35.7% relative reduction. Eligible-workspace admission completion was 43.8% in control and 44.1% in treatment, and account-level support time at the 90th percentile was 71 minutes in control and 74 minutes in treatment. The direction held in all three weekly cohorts and the November 10–16 stabilization cohort, with no unrelated pricing-page layout or UI change. This clears the predeclared path-quality threshold and both guardrails. Update the existing “Q4 Pricing Path Clarity Test — design brief” with the certified denominators, result, guardrails, attribution check, and my recommendation to adopt treatment for organic traffic while leaving every admission and acquisition boundary unchanged. Make clear that this supports fewer unsupported self-serve starts and a pricing-page rollout decision—not paid-acquisition economics, pipeline impact, forecast credit, revenue lift, or a change to Helio Start eligibility—and that treatment remains non-default pending Priya’s November 25 decision.

Message 003470 in history

Fact 156

The Q4 Pricing Path Clarity Test direction held across all three weekly cohorts and the November 10–16, 2025 stabilization cohort, with no unrelated pricing-page layout or UI change.

Source evidence (1)

003470Nov 19, 2025 / 09:18 UTC-06:00

Owen has certified the completed four-cohort Q4 Pricing Path Clarity Test read. Across 3,286 organic pricing-page sessions, there were 1,639 control and 1,647 treatment sessions. Among Helio Start eligibility-flow starts, 38 of 344 control starts (11.0%) versus 25 of 352 treatment starts (7.1%) routed out for an existing unsupported condition, a 35.7% relative reduction. Eligible-workspace admission completion was 43.8% in control and 44.1% in treatment, and account-level support time at the 90th percentile was 71 minutes in control and 74 minutes in treatment. The direction held in all three weekly cohorts and the November 10–16 stabilization cohort, with no unrelated pricing-page layout or UI change. This clears the predeclared path-quality threshold and both guardrails. Update the existing “Q4 Pricing Path Clarity Test — design brief” with the certified denominators, result, guardrails, attribution check, and my recommendation to adopt treatment for organic traffic while leaving every admission and acquisition boundary unchanged. Make clear that this supports fewer unsupported self-serve starts and a pricing-page rollout decision—not paid-acquisition economics, pipeline impact, forecast credit, revenue lift, or a change to Helio Start eligibility—and that treatment remains non-default pending Priya’s November 25 decision.

Message 003470 in history

Expected tool calls

  • create_doc

Grading

1. field_equals / create_doc
{
  "type": "field_equals",
  "tool": "create_doc",
  "action_id": "create_scorecard",
  "path": "result.ok",
  "value": true,
  "check_id": "riley_066_00"
}
2. field_equals / create_doc
{
  "check_id": "riley_066_01",
  "type": "field_equals",
  "tool": "create_doc",
  "action_id": "create_scorecard",
  "path": "args.title",
  "value": "Q4 Pricing Path Clarity Test — completed metric scorecard"
}
3. field_llm_judge / create_doc
{
  "type": "field_llm_judge",
  "tool": "create_doc",
  "action_id": "create_scorecard",
  "path": "args",
  "criterion": "The document accurately reports 3,286 organic pricing-page sessions in total, with 1,639 control sessions and 1,647 treatment sessions. Missing or contradictory counts fail.\n\nThe document accurately reports that, among Helio Start eligibility-flow starts, 38 of 344 control starts (11.0%) and 25 of 352 treatment starts (7.1%) routed out for an existing unsupported condition, representing a 35.7% relative reduction. Missing or contradictory denominators, counts, rates, or reduction fail.\n\nThe guardrail section accurately reports eligible-workspace admission completion of 43.8% in control and 44.1% in treatment, plus account-level support time at the 90th percentile of 71 minutes in control and 74 minutes in treatment. Missing or contradictory values fail.\n\nThe document states that the result direction held in all three weekly cohorts and in the final November 10–16 stabilization cohort, and that no unrelated pricing-page layout or UI change occurred. Missing or contradictory consistency or concurrent-change conclusions fail.",
  "check_id": "riley_066_02"
}
Complete grading specification
{
  "type": "tool_trace",
  "config": {
    "check_version": 2,
    "today": "2028-01-01",
    "semantic_judge_version": 2,
    "assertions": [
      {
        "type": "field_equals",
        "tool": "create_doc",
        "action_id": "create_scorecard",
        "path": "result.ok",
        "value": true,
        "check_id": "riley_066_00"
      },
      {
        "check_id": "riley_066_01",
        "type": "field_equals",
        "tool": "create_doc",
        "action_id": "create_scorecard",
        "path": "args.title",
        "value": "Q4 Pricing Path Clarity Test — completed metric scorecard"
      },
      {
        "type": "field_llm_judge",
        "tool": "create_doc",
        "action_id": "create_scorecard",
        "path": "args",
        "criterion": "The document accurately reports 3,286 organic pricing-page sessions in total, with 1,639 control sessions and 1,647 treatment sessions. Missing or contradictory counts fail.\n\nThe document accurately reports that, among Helio Start eligibility-flow starts, 38 of 344 control starts (11.0%) and 25 of 352 treatment starts (7.1%) routed out for an existing unsupported condition, representing a 35.7% relative reduction. Missing or contradictory denominators, counts, rates, or reduction fail.\n\nThe guardrail section accurately reports eligible-workspace admission completion of 43.8% in control and 44.1% in treatment, plus account-level support time at the 90th percentile of 71 minutes in control and 74 minutes in treatment. Missing or contradictory values fail.\n\nThe document states that the result direction held in all three weekly cohorts and in the final November 10–16 stabilization cohort, and that no unrelated pricing-page layout or UI change occurred. Missing or contradictory consistency or concurrent-change conclusions fail.",
        "check_id": "riley_066_02"
      }
    ]
  }
}
App stateDownload JSON
Source file

tests/riley/066.yaml

SHA-256: e1355d53fcf074aa1316d2ee9fdfe749623a2507e71603cedff6d7dc35bc6f2c